These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9357407)

  • 1. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):505-10. PubMed ID: 8757152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
    Beresford SA; Weiss NS; Voigt LF; McKnight B
    Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1996 Aug; 348(9026):498-505. PubMed ID: 8757151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and risk of glioma: a nationwide nested case-control study.
    Andersen L; Friis S; Hallas J; Ravn P; Gaist D
    Cancer Epidemiol; 2013 Dec; 37(6):876-80. PubMed ID: 24138870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy increases the risk of cranial meningioma.
    Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
    Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and risk of myocardial infarction: a national register study.
    Løkkegaard E; Andreasen AH; Jacobsen RK; Nielsen LH; Agger C; Lidegaard Ø
    Eur Heart J; 2008 Nov; 29(21):2660-8. PubMed ID: 18826989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk and hormone replacement therapy in menopause].
    Plu-Bureau G
    Therapie; 1999; 54(3):375-80. PubMed ID: 10500454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and stroke risk in older women.
    Fung MM; Barrett-Connor E; Bettencourt RR
    J Womens Health; 1999 Apr; 8(3):359-64. PubMed ID: 10326990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort.
    Finucane FF; Madans JH; Bush TL; Wolf PH; Kleinman JC
    Arch Intern Med; 1993 Jan; 153(1):73-9. PubMed ID: 8422201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study.
    Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Hundrup YA; Obel EB; Pedersen AT
    Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.